The future of postmenopausal hormone therapy: It's time to move forward

Maturitas

Volumn 57, Issue 1, 2007, Pages 103-106

  Speroff, Leon ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cardiovascular; Postmenopausal; Prevention

Indexed keywords

ARTICLE; CLINICAL STUDY; EVIDENCE BASED MEDICINE; HORMONAL THERAPY; HUMAN; INFORMATION CENTER; MEDICAL LITERATURE; MENOPAUSAL SYNDROME; WOMEN'S HEALTH;

CARDIOVASCULAR DISEASES; ESTROGEN REPLACEMENT THERAPY; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; JOURNALISM, MEDICAL; MASS MEDIA; PATIENT ACCEPTANCE OF HEALTH CARE; RANDOMIZED CONTROLLED TRIALS;

EID: 34247110308     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2007.02.024     Document Type: Article

References (13)

1. Salpeter S.R., Walsh J.M.E., Greyber E., and Salpeter E.E. Brief report: coronary heart disease events associated with hormone therpay in younger and older women. A meta-analysis. J Gen Intern Med 21 (2006) 363-366
2. Salpeter S.R., Walsh J.M.E., Greyber E., Ormiston T.M., and Salpeter E.E. Mortality associated with hormone replacement therapy in younger and older women. A meta-analysis. J Gen Intern Med 19 (2004) 791-804
3. Clarkson T.B., and Appt S. Controversies about HRT-lessons from monkey models. Maturitas 51 (2005) 64-74
4. Grodstein F., Manson J.E., and Stampfer M.J. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health (Larchmt) 15 (2006) 35-44
5. Prentice R.L., Langer R., Stefanick M.L., et al. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial. Am J Epidemiol 162 (2005) 404-414
6. Prentice R.L., Langer R.D., Stefanick M.L., et al. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascualr disease. Am J Epidemiol 163 (2006) 589-599
7. Lawlor D.A., Davey Smith G., and Ebrahim S. Commentary: the hormone replacement-coronary heart disease conundrum: is this the death of observational epidemiology?. Int J Epidemiol 33 (2004) 464-467
8. Stefanick M.L., Anderson G.L., Margolis K.L., et al. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA 295 (2006) 1647-1657
9. Stefanick M.L., Cochrane B.B., Hsia J., Barad D.H., Liu J.H., and Johnson S.R. The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants. Ann Epidemiol 13 (2003) S78-S86
10. Chen W., Petitti D.B., and Geiger A.M. Mortality following development of breast cancer while using oestrogen or oestrogen plus progestin: a computer record-linkage study. Br J Cancer 93 (2005) 392-398
11. Chen W.Y., Hankinson S.E., Schnitt S.J., Rosner B.A., Holmes M.D., and Colditz G.A. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma. Cancer 101 (2004) 1490-14500
12. Kerlikowske K., Miglioretti D.L., Ballard-Barbash R., et al. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. J Clin Oncol 21 (2003) 4314-4321
13. Jackson R.D., LaCroix A.Z., Gass M., et al. Calcium plus vitamin D supplementation and the risk of fractures. New Engl J Med 354 (2006) 669-683